China approved on Thursday an innovative nuclear medicine imaging agent developed by a research team led by Professor Wang Fan at Peking University. The agent is the world's first radioactive drug ...

2026年1月，西京医院核医学科汪静教授、康飞教授团队在期刊《EJNMMI Physics》（JCR1区）在线发表了一项前瞻性临床研究，题为“Clinical validation of a unified data-driven respiratory motion correction technique in18F-FDG PET/CT imaging of upper abdominal ...

GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body positron emission tomography/computed tomography (PET/CT) technology for new clinical pathways to help ...

Over 95% of TB deaths occur in low- and middle-income Member States, where TB is among the top three causes of death for women in reproductive age. This disease has become or is becoming a medical ...

Researchers report that a new nuclear medicine tracer may allow better diagnosis of acute venous thromboembolism (VTE). Acute VTE is a disease that includes deep-vein thrombosis and its complication, ...

Peter Waterman, Product Manager, Imaging Applications, Perkin Elmer, introduces the G8 PET/CT preclinical imaging platform. The highly versatile, benchtop G8 system allows you to adopt PET imaging ...

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...

Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed.

Detection of prostate cancer and its recurrence is challenging as it is a heterogeneous disease and methods such as PET imaging and measurement of biochemical response using prostate specific membrane ...